{"id":"NCT03214367","sponsor":"Eli Lilly and Company","briefTitle":"A Study of LY900014 in Participants With Type 1 Diabetes","officialTitle":"A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-07-17","primaryCompletion":"2018-09-06","completion":"2019-08-22","firstPosted":"2017-07-11","resultsPosted":"2020-05-01","lastUpdate":"2020-05-01"},"enrollment":1392,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 1 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"LY900014","otherNames":["Ultra-Rapid Lispro"]},{"type":"DRUG","name":"Insulin Lispro","otherNames":["Humalog"]},{"type":"DRUG","name":"Insulin Glargine","otherNames":[]},{"type":"DRUG","name":"Insulin Degludec","otherNames":[]}],"arms":[{"label":"LY900014","type":"EXPERIMENTAL"},{"label":"Insulin Lispro (Humalog)","type":"ACTIVE_COMPARATOR"},{"label":"LY900014 Postmeal (Open Label)","type":"EXPERIMENTAL"},{"label":"LY900014 - Maximum Extended Enrollment (MEE)","type":"EXPERIMENTAL"},{"label":"Insulin Lispro (Humalog)-MEE","type":"ACTIVE_COMPARATOR"},{"label":"LY900014 Postmeal (Open Label)-MEE","type":"EXPERIMENTAL"}],"summary":"The main purpose of this study is to evaluate the efficacy of the study drug LY900014 compared to insulin lispro, both in combination with insulin glargine or insulin degludec, in adults with type 1 diabetes (T1D).","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) Efficacy Estimand at Week 26","timeFrame":"Baseline, Week 26","effectByArm":[{"arm":"LY900014","deltaMin":-0.13,"sd":0.031},{"arm":"LY900014 Postmeal","deltaMin":0.08,"sd":0.035},{"arm":"Insulin Lispro (Humalog)","deltaMin":-0.05,"sd":0.031}],"pValues":[{"comp":"OG000 vs OG002","p":"0.060"},{"comp":"OG001 vs OG002","p":"0.003"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":172,"countries":["United States","Argentina","Australia","Austria","Brazil","Germany","Greece","India","Italy","Japan","Mexico","New Zealand","Poland","Puerto Rico","Romania","Russia","Slovakia","Spain","Sweden","Taiwan"]},"refs":{"pmids":["38035641","34347267","33458803","32728832"],"seeAlso":["https://www.lillytrialguide.com/en-US/studies/type-1-diabetes/ITRM#?postal="]},"adverseEventsSummary":{"seriousAny":{"events":48,"n":1316},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Influenza","Cough","Pyrexia"]}}